Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence

Table 30 Endoscopic submucosal dissection

Ref.	Year	Country	Study design	n	Procedure	Medication	Relative risk
Igarashi et al[56]	2017	Japan	Retrospective	90	Gastric ESD	Thienopyridines either: (1) Continued until day of; (2) Ceased 3-7 d before	Incidence of PPB 5.6% (continued). Incidence of PPB 12.5% (ceased)
Ono et al[128]	2017	Japan	Prospective	10	Gastric ESD	Thienopyridines (continued)	Incidence of PPB 20%
Sato et al[57]	2017	Japan	Retrospective	19	Gastric ESD	Thienopyridines(ceased 5-7 d before)	No incidence of PPB
Oh et al[116]	2018	South Korea	Retrospective	56	Gastric ESD	Thienopyridines either: (1) Ceased 0-4 d before; (2) Ceased 5-7 d before	Incidence of PPB 3.6%
Nam et al[118]	2019	South Korea	Retrospective	31	Gastric ESD	Thienopyridines(ceased 7 d before)	Incidence of PPB 19.4%

ESD: Endoscopic submucosal dissection; PPB: Post-procedural bleeding.